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Résumé en
anglais
The cardiotoxicity of 5-fluorouracil (FU) was attributed to degradation compounds
present in the injected vials, fluoroacetaldehyde (Facet) and fluoromalonaldehydic
acid (FMald). These compounds are formed with time in the basic medium
necessary to solubilize FU. FU-NaOH vials were much less cardiotoxic than FU-
Tris vials on the isolated perfused rabbit heart model since, in FU-Tris vials, Facet
and FMald are stored in stable "depot" forms, which are adducts with Tris,
whereas, in FU-NaOH vials, they are extensively chemically transformed.
Cardiotoxic fluoroacetate (FAC), arising from Facet metabolization, was found in
urine of patients, with a ratio FAC/FU catabolites 10-30 fold lower in patients
treated with FU-NaOH than in those treated with FU-Tris.
URL de la
notice http://okina.univ-angers.fr/publications/ua5691 [14]



















Publié sur Okina (http://okina.univ-angers.fr)
